Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.

Wan Z, Zhi N, Wong S, Keyvanfar K, Liu D, Raghavachari N, Munson PJ, Su S, Malide D, Kajigaya S, Young NS.

J Clin Invest. 2010 Oct;120(10):3530-44. doi: 10.1172/JCI41805. Epub 2010 Sep 20.

2.

Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.

Luo Y, Kleiboeker S, Deng X, Qiu J.

J Virol. 2013 Dec;87(23):12766-75. doi: 10.1128/JVI.02333-13. Epub 2013 Sep 18.

3.

Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα.

Chen AY, Kleiboeker S, Qiu J.

PLoS Pathog. 2011 Jun;7(6):e1002088. doi: 10.1371/journal.ppat.1002088. Epub 2011 Jun 16.

4.

Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.

Wong S, Zhi N, Filippone C, Keyvanfar K, Kajigaya S, Brown KE, Young NS.

J Virol. 2008 Mar;82(5):2470-6. Epub 2007 Dec 26.

5.

The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells.

Chen AY, Zhang EY, Guan W, Cheng F, Kleiboeker S, Yankee TM, Qiu J.

Blood. 2010 Feb 4;115(5):1070-80. doi: 10.1182/blood-2009-04-215756. Epub 2009 Oct 27.

6.

Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.

Chen AY, Guan W, Lou S, Liu Z, Kleiboeker S, Qiu J.

J Virol. 2010 Dec;84(23):12385-96. doi: 10.1128/JVI.01229-10. Epub 2010 Sep 22.

7.

Parvovirus B19 NS1 protein induces cell cycle arrest at G2-phase by activating the ATR-CDC25C-CDK1 pathway.

Xu P, Zhou Z, Xiong M, Zou W, Deng X, Ganaie SS, Kleiboeker S, Peng J, Liu K, Wang S, Ye SQ, Qiu J.

PLoS Pathog. 2017 Mar 6;13(3):e1006266. doi: 10.1371/journal.ppat.1006266. eCollection 2017 Mar.

8.

Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M.

Lou S, Luo Y, Cheng F, Huang Q, Shen W, Kleiboeker S, Tisdale JF, Liu Z, Qiu J.

J Virol. 2012 Oct;86(19):10748-58. doi: 10.1128/JVI.01007-12. Epub 2012 Jul 25.

9.

Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.

Bua G, Manaresi E, Bonvicini F, Gallinella G.

PLoS One. 2016 Feb 4;11(2):e0148547. doi: 10.1371/journal.pone.0148547. eCollection 2016.

10.

Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process.

Adamson-Small LA, Ignatovich IV, Laemmerhirt MG, Hobbs JA.

Virus Res. 2014 Sep 22;190:8-16. doi: 10.1016/j.virusres.2014.06.017. Epub 2014 Jul 3. Review.

PMID:
24998884
11.

Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.

Wolfisberg R, Ruprecht N, Kempf C, Ros C.

J Virol Methods. 2013 Oct;193(1):215-25. doi: 10.1016/j.jviromet.2013.06.003. Epub 2013 Jun 10.

PMID:
23764418
12.

Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice.

Chen Q, Liang D, Yang T, Leone G, Overbeek PA.

Dev Neurosci. 2004;26(5-6):435-45.

PMID:
15855772
13.

Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase.

Morita E, Nakashima A, Asao H, Sato H, Sugamura K.

J Virol. 2003 Mar;77(5):2915-21.

14.

Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.

Schmidt-Lucke C, Zobel T, Schrepfer S, Kuhl U, Wang D, Klingel K, Becher PM, Fechner H, Pozzuto T, Van Linthout S, Lassner D, Spillmann F, Escher F, Holinski S, Volk HD, Schultheiss HP, Tschope C.

J Infect Dis. 2015 Oct 1;212(7):1070-81. doi: 10.1093/infdis/jiv178. Epub 2015 Mar 24.

PMID:
25805750
15.

Antiviral effect of cidofovir on parvovirus B19 replication.

Bonvicini F, Bua G, Manaresi E, Gallinella G.

Antiviral Res. 2015 Jan;113:11-8. doi: 10.1016/j.antiviral.2014.11.004. Epub 2014 Nov 13.

PMID:
25446336
16.

Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells.

Bonvicini F, Bua G, Conti I, Manaresi E, Gallinella G.

Biochem Pharmacol. 2017 Jul 15;136:32-39. doi: 10.1016/j.bcp.2017.03.022. Epub 2017 Apr 2.

PMID:
28377277
17.

Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.

Thammasri K, Rauhamäki S, Wang L, Filippou A, Kivovich V, Marjomäki V, Naides SJ, Gilbert L.

PLoS One. 2013 Jun 12;8(6):e67179. doi: 10.1371/journal.pone.0067179. Print 2013.

18.
19.

Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation.

Maiti B, Li J, de Bruin A, Gordon F, Timmers C, Opavsky R, Patil K, Tuttle J, Cleghorn W, Leone G.

J Biol Chem. 2005 May 6;280(18):18211-20. Epub 2005 Feb 18.

20.

Human parvovirus B19 infection leads to downregulation of thyroid, estrogen, and retinoid hormone receptor expression.

Ignatovich IV, Hobbs JA.

Virology. 2013 Nov;446(1-2):173-9. doi: 10.1016/j.virol.2013.06.022. Epub 2013 Aug 28.

Supplemental Content

Support Center